Re: bisphosphonate question new qs

[Guest guest]

hi alena. according to the sdcep bisphosphonate guidance,The incidence of ONJ in thegeneral population is unknown. Estimates of ONJ in patients taking bisphosphonates range from 1 in 10,000to < 1 in 100,000 persons per years’ exposurehope this helps.regards priya <p><a Target="_top" href="http://www.flamingtext.com/hmail.html" ><img src=" " border=0 alt="Image by FlamingText.com"></a><br>Image by <a href="http://www.flamingtext.com/hmail2.html" >FlamingText.com</a></BODY></HTML> From: Alena Ozieva <alenaozieva@...> " " < >

Sent: Saturday, 21 July 2012, 12:54 Subject: new qs

Hi guys

The risk

of developing osteonecrosis of the jaw when receiving intravenous Bisphosphonates

is roughly

1:10

1:1000

1:10,000

1:1,000,000

Kind regardsAlenaOzieva